Treatment of Wilson's disease with tetrathiomolybdate: V. control of free copper by tetrathiomolybdate and a comparison with trientine

Translational Research

Volumn 154, Issue 2, 2009, Pages 70-77

  Brewer, George J ^a   Askari, Fred ^a   Dick, Robert B ^a   Sitterly, Julia ^a   Fink, John K ^a   Carlson, Martha ^b   Kluin, Karen J ^a,b   Lorincz, Matthew T ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CERULOPLASMIN; COPPER; TETRATHIOMOLYBDIC ACID; TRIENTINE; ZINC;

AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ARTICLE; BEDTIME DOSAGE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED STUDY; COPPER BLOOD LEVEL; DOUBLE BLIND PROCEDURE; FOOD; HUMAN; LEUKOPENIA; MAJOR CLINICAL STUDY; NEUROLOGY; OPEN STUDY; PRIORITY JOURNAL; SIDE EFFECT; WILSON DISEASE;

EID: 67649874760     PISSN: 19315244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trsl.2009.05.002     Document Type: Article

References (20)

1. Brewer G.J., Dick R.D., Johnson V.D., Brunberg J.A., Kluin K.J., and Fink J.K. Treatment of Wilson's disease with zinc: XV long-term follow-up studies. J Lab Clin Med 132 (1998) 264-278
2. Brewer G.J. Wilson's disease. In: Fauci A.S., Braunward E., and Kasper D.L. (Eds). Harrison's principles of internal medicine. 17th ed (2008), McGraw-Hill, New York 2449-2452
3. Walshe J.M. Treatment of Wilson's disease with trientine (triethylene tetramine) dihydrochloride. Lancet 1 (1982) 643-647
4. Brewer G.J., Terry C.A., Aisen A.M., and Hill G.M. Worsening of neurologic syndrome in patients with Wilson's disease with initial penicillamine therapy. Arch Neurol 44 (1987) 490-493
5. Brewer G.J., Askari F., Lorincz M.T., et al. Treatment of Wilson disease with ammonium tetrathiomolybdate: IV. Comparison of tetrathiomolybdate and trientine in a double-blind study of treatment of the neurologic presentation of Wilson disease. Arch Neurol 63 (2006) 521-527
6. Brewer G.J., Dick R.D., Yuzbasiyan-Gurkan V., Tankanow R., Young A.B., and Kluin K.J. Initial therapy of patients with Wilson's disease with tetrathiomolybdate. Arch Neurol 48 (1991) 42-47
7. Mills C.F., El-Gallad T.T., and Bremner I. Effects of molybdate, sulfide, and tetrathiomolybdate on copper metabolism in rats. J Inorg Biochem 14 (1981) 189-207
8. Bremner I., Mills C.F., and Young B.W. Copper metabolism in rats given di- or trithiomolybdates. J Inorg Biochem 16 (1982) 109-119
9. Mills C.F., El-Gallad T.T., Bremner I., and Weham G. Copper and molybdenum absorption by rats given ammonium tetrathiomolybdate. J Inorg Biochem 14 (1981) 163-175
10. Gooneratne S.R., Howell J.M., and Gawthorne J.M. An investigation of the effects of intravenous administration of thiomolybdate on copper metabolism in chronic Cu-poisoned sheep. Br J Nutr 46 (1981) 469-480
11. Brewer G.J., Hedera P., Kluin K.J., et al. Treatment of Wilson disease with ammonium tetrathiomolybdate: III. Initial therapy in a total of 55 neurologically affected patients and follow-up with zinc therapy. Arch Neurol 60 (2003) 379-385
12. Brewer GJ, Askari F, Lorincz MT, et al. Treatment of Wilson's disease with ammonium tetrathiomolybdate: VI. New dosage regimen to reduce side effects. unpublished work.
13. Brewer G.J., and Yuzbasiyan-Gurkan V. Wilson disease. Medicine 71 (1992) 139-164
14. Ala A., Walker A.P., Ashkan K., Dooley J.S., and Schilsky M.L. Wilson's disease. Lancet 369 (2007) 397-408
15. Scheinberg I.H., and Sternlieb I. Wilson's disease. In: Smith L.H.J. (Ed). Major problems in internal medicine (1984), W.B. Saunders, Philadelphia, PA 1-171
16. Young A.B., Shoulson I., Penney J.B., et al. Huntington's disease in Venezuela: neurologic features and functional decline. Neurology 36 (1986) 244-249
17. Stuerenburg H.J. CSF copper concentrations, blood-brain barrier function, and coeruloplasmin synthesis during the treatment of Wilson's disease. J Neural Transm 107 (2000) 321-329
18. Schosinsky K.H., Lehmann H.P., and Beeler M.F. Measurement of ceruloplasmin from its oxidase activity in serum by use of o-dianisidine dihydrochloride. Clin Chem 20 (1974) 1556-1563
19. Brewer G.J., Turkay A., and Yuzbaziyan-Gurkan V. Development of neurologic symptoms in a patient with asymptomatic Wilson's disease treated with penicillamine. Arch Neurol 51 (1994) 304-305
20. Glass J.D., Reich S.G., and DeLong M.R. Wilson's disease. Development of neurological disease after beginning penicillamine therapy. Arch Neurol 47 (1990) 595-596